-
Mashup Score: 1
Compared with rivaroxaban, patients who received apixaban had a 43% reduced risk of stroke or embolism.
Source: www.mdedge.comCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 2Comparison of dabigatran, rivaroxaban, and apixaban for effectiveness and safety in atrial fibrillation: a nationwide cohort study - 2 year(s) ago
AbstractAims. The aim of this study was to compare the risk of stroke or systemic embolism (SE) and major bleeding in patients with atrial fibrillation (AF) usi
Source: OUP AcademicCategories: Cardiologists, Latest HeadlinesTweet-
Comparison of #dabigatran #rivaroxaban, and #apixaban : a nationwide cohort study #AF https://t.co/degbjOMH3H
-
-
Mashup Score: 2
Original Article from The New England Journal of Medicine ā Rivaroxaban in Rheumatic Heart DiseaseāAssociated Atrial Fibrillation
Source: New England Journal of MedicineCategories: Hem/Oncs, Latest HeadlinesTweet-
.#NEJM: Among patients with #rheumatic #HeartDisease-associated atrial #fibrillation, vitamin K antagonist therapy led to a lower rate of a composite of #cardiovascular events or death than #rivaroxaban therapy, without a higher rate of bleeding. #INVICTUS https://t.co/xpxplocoSG https://t.co/PQGUMiK5RE
-
-
Mashup Score: 3
Original Article from The New England Journal of Medicine ā Rivaroxaban in Rheumatic Heart DiseaseāAssociated Atrial Fibrillation
Source: New England Journal of MedicineCategories: Hem/Oncs, Latest HeadlinesTweet-
In patients with atrial fibrillation and rheumatic heart disease compared to Rivaroxaban, warfarin was associated with less cardiovascular events without an increase in bleeding. https://t.co/jw3C1fEeuo #AF #rivaroxaban #warfarin https://t.co/6HOeK3Pjhy
-
-
Mashup Score: 0
(UPDATED) Investigators were āfloored by the results,ā and canāt understand why the DOAC was linked with higher mortality.
Source: TCTMD.comCategories: Cardiologists, Latest HeadlinesTweet-
#INVICTUS: More Deaths, Stroke With #Rivaroxaban in #Rheumatic Heart Disease #AFib Investigators were āfloored by the results,ā and canāt understand why the #DOAC was linked with higher ā ļø https://t.co/XB3LneMRB2 @escardio @TCTMD @DrMarthaGulati @mmamas1973 @dr_benoy_n_shah https://t.co/M2Mqcqbv9c
-
-
Mashup Score: 2Xarelto Risky in Rheumatic Heart Disease - 2 year(s) ago
Ischemic event prevention didn’t pan out in INVICTUS trial
Source: www.medpagetoday.comCategories: Cardiology News and Journals, Latest HeadlinesTweet-
#ESCCongress: #Rivaroxaban (#Xarelto) appeared risky for treating #atrialfibrillation in #rheumaticheartdisease, the INVICTUS trial showed: https://t.co/4VCXkLvypn @escardio @medpagetoday @cphend @drkarthik2010
-
-
Mashup Score: 1Rivaroxaban Monotherapy in Atrial Fibrillation and Stable Coronary Artery Disease Across Body Mass Index Categories: - 2 year(s) ago
Abstract Background The AFIRE (Atrial Fibrillation and Ischemic Events With Rivaroxaban in Patients With Stable Coronary Artery Disease) trial showed both noninferiority for efficacy and superiorit…
Source: JACC: AsiaCategories: Expert Picks, Latest HeadlinesTweet-
#ESCCongress #JACCAsia SimPub: This post-hoc analysis of #AFIRE trial showed #rivaroxaban monotherapy had a similar effect on prognosis across all #BMI categories in patients w/ #AFib & stable #cvCAD. Further studies still needed. https://t.co/TzUmlaAoWE #CardioTwitter #ACCIntl https://t.co/btcZYOMn0K
-
-
Mashup Score: 0
Skip Nav Destination July 25, 2022 Use of rivaroxaban was superior to placebo for the extended prevention of venous thromboembolism (VTE) in patients after they underwent laparoscopic surgery for colorectal cancer, according to results from the…
Source: ashpublications.orgCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
Use of #rivaroxaban was superior to placebo for the extended prevention of #VTE in patients after undergoing #laparoscopic surgery for #colorectal #cancer, according to results from the PROLAPS-II study https://t.co/R5x3ihvcE9
-
-
Mashup Score: 1
Skip Nav Destination June 27, 2022 Treatment with rivaroxaban was effective for managing splanchnic vein thrombosis (SVT) in non-cirrhotic patients, according to the results of a study published in Blood Advances. Study results suggest the oral…
Source: ashpublications.orgCategories: Hem/Oncs, Latest HeadlinesTweet-
#Rivaroxaban was effective for managing #splanchnic #vein #thrombosis in non-cirrhotic patients, with study results suggesting it could serve as an alternative to standard #anticoagulation https://t.co/W8KK1ANTId
-
-
Mashup Score: 3Rivaroxaban for the treatment of noncirrhotic splanchnic vein thrombosis: an interventional prospective cohort study - 2 year(s) ago
Key Points. SVT is a potentially life-threatening disease associated with a substantial risk of recurrence and bleeding.Rivaroxaban appears to be a reasonable a
Source: American Society of HematologyCategories: Hem/Oncs, Latest HeadlinesTweet-
Small prospective study, short follow-up, but it suggests that Rivaroxaban is a reasonable option for splanchnic vein thrombosis. https://t.co/ca4Oo0PDb4 #thrombosis #Rivaroxaban #DOAC #Splanchnic https://t.co/bwivZFG6ZU
-
#Apixaban outmatches #Rivaroxaban in patients with #AFib and valvular heart diseaseš https://t.co/mFxC4Lz2X3 @MDedgeHemOnc @PennMDForum #VHD #Penn https://t.co/TNzpbSxleU